In conclusion, this study is the first to show that 3,3′,4,5′-TMS could improve IR in HepG2 cells by inhibiting oxidative stress and activating the IRS/PI3K/Akt pathway, indicating the potential of 3,3′,4,5′-TMS for the treatment of diabetes (Figure 5). This evidence concerns the gene AKT1 and diabetes mellitus.